CEO Robert Ford also plans to expand sales of the company’s Lingo over-the-counter glucose sensors after a limited rollout.

Minnesota system treating atrial fibrillation helped sustain Boston Scientific’s streak of bullish results as the company ...

A pair of investor calls on Jan. 22 added clarity to the rapidly evolving cardiac ablation market with Abbott Laboratories and Johnson & Johnson providing updates on their pulsed field ablation ...

Portland, Oregon, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Introspective Market Research is pleased to announce the publication of its latest report, Ablation Devices Market. This in-depth analysis shows ...

Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...

The Volt PFA system. [Image courtesy of Abbott] Abbott announced the first global procedures using its Volt pulsed field ablation in January 2024. Volt treats patients who are battling common ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

In 2024, Abbott's EP business demonstrated strength thanks to its preferred mapping systems, even though it is late to market with its own pulsed field ablation technology. However, EP growth ...